Sucampo Pharma Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUCAMPO PHARMA LLC, and when can generic versions of SUCAMPO PHARMA LLC drugs launch?
SUCAMPO PHARMA LLC has two approved drugs.
There are five US patents protecting SUCAMPO PHARMA LLC drugs.
There are seventy patent family members on SUCAMPO PHARMA LLC drugs in nineteen countries and five supplementary protection certificates in five countries.
Summary for Sucampo Pharma Llc
International Patents: | 70 |
US Patents: | 5 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Drugs and US Patents for Sucampo Pharma Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | AB | RX | Yes | Yes | 8,026,393 | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-002 | Apr 29, 2008 | AB | RX | Yes | No | 7,795,312 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | AB | RX | Yes | Yes | 8,779,187 | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sucampo Pharma Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | 6,414,016 | ⤷ Try a Trial |
Sucampo Pharma Llc | RESCULA | unoprostone isopropyl | SOLUTION/DROPS;OPHTHALMIC | 021214-001 | Aug 3, 2000 | 5,212,200 | ⤷ Try a Trial |
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-002 | Apr 29, 2008 | 6,414,016 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUCAMPO PHARMA LLC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 8 mcg and 24 mcg | ➤ Subscribe | 2012-08-20 |
➤ Subscribe | Ophthalmic Solution | 0.15% | ➤ Subscribe | 2014-05-12 |
International Patents for Sucampo Pharma Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2510051 | ⤷ Try a Trial |
China | 101410097 | ⤷ Try a Trial |
China | 104983712 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sucampo Pharma Llc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0289349 | C300135 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: UNOPROSTONEZUUR, DESGEWENST IN DE VORM VAN EEN ESTER OF EEN ZOUT; NATL REGISTRATION NO/DATE: RVG 28628 20030708; FIRST REGISTRATION: FR 359 911-5 AND 359 912-1 20020917 |
2298314 | 92826 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: LUBIPROSTONE, INCLUANT LES SELS PHARMACEUTIQUEMENT ACCEPTABLES, LES ESTERS OU LES AMIDES DE LA LUBIPROSTONE. FIRST REGISTRATION: 20120910 |
1315485 | 2015C/048 | Belgium | ⤷ Try a Trial | PRODUCT NAME: LUBIPROSTONE; AUTHORISATION NUMBER AND DATE: PL21341/0003 20150317 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.